Physician profile
Jun A Garcia
NPI 1750356325
$8,567.86
in general payments reported to CMS, 2019-2025
41 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $1,686 · 2021: $1,409 · 2022: $1,293 · 2023: $1,328 · 2024: $1,113 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,461.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,126.19 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,114.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $915.13 | 2019-2025 | |
| Abbvie INC. | $625.36 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $578.88 | 2019-2024 | Jardiance, Tradjenta |
| Lilly USA, LLC | $498.81 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $477.78 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $364.98 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $337.39 | 2021-2025 | |
| Harmony Biosciences LLC | $289.97 | 2020-2023 | Wakix |
| Idorsia Pharmaceuticals US INC | $273.85 | 2022-2024 | Quviviq |
| Amgen INC. | $236.35 | 2020-2025 | Repatha, Otezla, Repatha |
| Indivior INC. | $203.81 | 2019-2024 | Sublocade |
| Amarin Pharma, INC. | $192.59 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.19 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.